Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
CHRU , Hôpital Claude Huriez, Lille, France
Hospital Serdang, Kajang, Selangor, Malaysia
Hospital Kuala Lumpur, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
KK Women's and Children's Hospital, Singapore, Singapore
Denver Veterans Affairs Medical Center, Denver, Colorado, United States
ASST Cremona, Creom, Cremona, Italy
School & Hospital of Stomatology, China Medical University, Shenyang, Liaoning, China
Rush University Medical Center, Chicago, Illinois, United States
Banha University, Banha, Qalubia, Egypt
the Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.